Variant · Snv
CLCN2 NM_004366.6(CLCN2):c.898+1G>A
CI-VAR-00197795Explore in graph →NM_004366.6:c.898+1G>AClinVar 1194517 rs141074059
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-06
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260908-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1194517 | Likely pathogenic | criteria provided, multiple submitters, no conflicts | 2 | Familial hyperaldosteronism type II; Epilepsy, idiopathic generalized, susceptibility to, 11; Leukoencephalopathy with mild cerebellar ataxia and white matter edema; Uterine corpus endometrial carcinoma | germline | 4 | Mar 04, 2024 | clinvar |